141 research outputs found

    PHYSICOCHEMICAL AND MECHANICAL PROPERTIES OF CROFER 22 APU FERRITIC STEEL APPLIED IN SOFC INTERCONNECTS

    Get PDF
    The paper presents the results of investigations of the physicochemical and mechanical properties of the Crofer 22 APU steel designed for application in metallic interconnects forming the key components of solid oxide fuel cells (SOFCs). Microstructural and hardness studies of non-metallic inclusions and the matrix were carried out. Based on compression tests of raw Crofer 22 APU and the steel after 600 hrs of cyclic oxidation in air at 800°C, the composition of non-metallic inclusions and their influence on the strength properties of the steel were determined

    Dental Findings in Cornelia De Lange Syndrome

    Get PDF
    Cornelia de Lange syndrome is a congenital disease, basically characterized by psychomotor retardation associated with a series of malformations, including mainly skeletal, craniofacial deformities together with gastrointestinal and cardiac malformations. There is no definitive biochemical or chromosomal marker for the prenatal diagnosis of this syndrome. We actually want to present the case of a 10-year-old patient, who was admitted to our clinic for dental pain. The patient had the symptoms of Cornelia de Lange syndrome. During the oral examination of this patient, the patient was found to have the typical symptoms of Cornelia de Lange syndrome, such as micrognathia and delayed eruption in conjunction with the symptoms of the Hutchinson's syndrome, which had never been reported before

    Experimental review of the performances of protective coatings for interconnects in solid oxide fuel cells

    Get PDF
    Ferritic stainless steel interconnects are used in solid oxide fuel cells; however, coatings are required to improve their performance. Although several types of coatings have been proposed, they have been scarcely investigated under similar conditions. This study compares the characteristics of uncoated Crofer 22 APU and eight different coatings on Crofer 22 APU for up to 3000\ua0h at 800\ua0\ub0C. The coatings were deposited at various research laboratories around the world, and the experiments were performed at Chalmers University of Technology, Sweden. Cross-sections of the samples were analysed using scanning electron microscopy and energy-dispersive x-ray spectroscopy. The (Co,Mn)-based coated steels showed more than 50-fold lower chromium evaporation and at least 3 times thinner Cr2O3 scale thickness compared to uncoated steel. The coated steel samples showed lower area-specific resistance (ASR) values than the uncoated steel after 3000\ua0h of exposure, irrespective of the coating thickness, composition and deposition method

    Maladaptive behaviors are linked with inefficient sleep in individuals with developmental disabilities

    Get PDF
    The purpose of the current study was to assess the relations between nightly sleep patterns and the frequency of daily maladaptive behavior. Antecedent and consequential relations between sleep patterns and behavior were evaluated with time series analysis. Sleep efficiency and maladaptive behavior were determined for 20 female residents of an institutional care facility for adults with developmental disabilities. Daily maladaptive behavioral data and nightly sleep/awake logs were collected for 4 months for each participant. Efficient sleep patterns were significantly associated with lower frequencies of maladaptive behaviors. All lagged cross-correlations 8 days before and 8 days after an evening of sleep were significant. These findings suggested that inefficient sleep was associated with increased maladaptive behaviors and that the lagged associations reflected a chronic but not an acute linkage between sleep and behavior

    A pilot randomised controlled trial of community-led ANtipsychotic Drug REduction for adults with learning disabilities

    Get PDF
    Background Data suggest that approximately 50,000 adults with learning disabilities (LDs) in England and Wales are currently prescribed antipsychotic medication. Illness in this population is common, including significant rates of challenging behaviour and mental illness, but there is particular concern over the use of antipsychotics prescribed for reasons other than the treatment of psychosis. Control of challenging behaviour is the primary reason why such medications are prescribed despite the absence of good evidence for any therapeutic effect for this purpose. Objectives To assess the feasibility of recruitment and retention and to explore non-efficacy-based barriers to a blinded antipsychotic medication withdrawal programme for adults with LDs without psychosis compared with treatment as usual. A secondary objective was to compare trial arms regarding clinical outcomes. Design A two-arm individually randomised double-blind placebo-controlled drug reduction trial. Setting Recruitment was through community learning disability teams (CLDTs) in south Wales and south-west England. Participants Adults with LDs who are prescribed risperidone for treatment of challenging behaviour with no known current psychosis or previous recurrence of psychosis following prior drug reduction. Intervention A double-blind drug reduction programme leading to full withdrawal within 6 months. Treatment in the intervention group was gradually reduced over a 6-month period and then maintained at the same level for a further 3 months, still under blind conditions. In the control group, the baseline level of medication was maintained throughout the 9-month period. The blind was broken at 9 months, following final data collection. Main outcome measures Feasibility outcomes were (1) the number and proportion of general practices/CLDTs that progressed from initial approach to recruitment of participants and (2) the number and proportion of recruited participants who progressed through the various stages of the study. Trial arms were also compared regarding clinical outcomes, the Modified Overt Aggression Scale, the Aberrant Behaviour Checklist, the Psychiatric Assessment Schedule for Adults with Developmental Disability checklist, the Antipsychotic Side-effect Checklist, the Dyskinesia Identification System Condensed User Scale, the Client Service Receipt Inventory, use of other interventions to manage challenging behaviour, use of as-required (pro re nata) medication and level of psychotropic medication use. Results Of the 22 participants randomised (intervention, n = 11; control, n = 11), 13 (59%) achieved progression through all four stages of reduction. Follow-up data at 6 and 9 months were obtained for 17 participants (intervention, n = 10; and control, n = 7; 77% of those randomised). There were no clinically important changes in participants’ levels of aggression or challenging behaviour at the end of the study. There were no expedited safety reports. Four adverse events and one serious adverse event were reported during the trial. Limitations Recruitment was challenging, which was largely a result of difficulty in identifying appropriate persons to consent and carer concerns regarding re-emergence of challenging behaviour. Reduced recruitment meant that the full trial became an exploratory pilot study. Conclusions The results indicate that drug reduction is possible and safe. However, concerns about taking part were probably exacerbated by limited availability of alternative (behavioural) interventions to manage behaviour; therefore, focused support and alternative interventions are required. The results of the qualitative study provide important insights into the experiences of people taking part in drug reduction studies that should influence future trial development. Future work We recommend that further work focuses on support for practitioners, carers and patients in reducing antipsychotic medication. Trial registration Current Controlled Trials ISRCTN38126962

    Interface Reactions between Conductive Ceramic Layers and Fe-Cr Steel Substrates in SOFC Operating Conditions

    No full text
    To improve contact resistance and protect the cathode from chromium poisoning, perovskite (La,Sr)CrO3, (La,Sr)CoO3 and spinel MnCo2O4 coatings were applied onto the surfaces of Fe-25Cr (DIN 50049) steel by means of the screen-printing method. The oxidation process of the coated steels under cyclic-oxidation conditions showed high compactness of the protective layer, good adhesion to the metal substrate, as well as acceptable area specific resistance level for SOFC metallic interconnect materials, which was the result of the structural modification of the coating/steel interface reaction, i.e. the formation of an intermediate, chromia-rich multilayer between the conductive coating and the metal substrate. The cross-sectional morphology and nanostructure of interface products formed during long-term thermal oxidation in air and the H2/H2O gas mixture at 1073K were characterized using SEM-EDS and conventional TEM-SAD. Cr-vaporization tests showed that the perovskite and spinel coatings may play the role of barriers that effectively decrease the volatilization rate of chromia species. [doi:10.2320/matertrans.MB201013
    corecore